Published in TB and Outbreaks Week, January 7th, 2003
"The pathogenic yeast Candida albicans displays at its cell surface beta-1,2 oligomannosides (beta-1,2-Mans)," explained Francoise Dromer and colleagues at the Pasteur Institute and Ecole Normale Superieure in Paris, the University of Lille Hospital Center in Lille, and the University of Angers in Angers.
Synthetic beta-1,2-Man analogs virtually abolished intestinal C. albicans colonization in animals, Dromer and coauthors found.
The researchers evaluated the effects of synthetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.